Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Gang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6067-6959; OpenAlex author ID A5100389218. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. OCIAD2-IQGAP1 interaction promotes pancreatic cancer progression by suppressing oxidative stress and mitochondria-mediated apoptosis. Co-author DOI 10.1016/j.cellsig.2025.112217↗
  2. DPP4 suppresses pancreatic cancer growth by enhancing ferroptosis sensitivity through stabilization of ACSL4. Last author DOI 10.1016/j.cellsig.2026.112446↗
  3. PRMT1 oligomerization regulates RNA-binding protein cascade to promote pancreatic cancer. Co-author DOI 10.26508/lsa.202503202↗
  4. Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study. Last author DOI 10.1111/ajco.13936↗
  5. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis. Last author DOI 10.3390/cancers16081540↗
  6. Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways. Co-author DOI 10.2174/1871520622666220509174306↗
  7. NQO-1 Enzyme-Activated NIR Theranostic Agent for Pancreatic Cancer. First author DOI 10.1021/acs.analchem.2c01189↗
  8. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. Last author DOI 10.1186/s12885-021-08962-7↗
  9. Dipeptidyl Peptidase-4 modulates Long-chain Acyl-CoA synthetase 4 to Promote Lipid Peroxidation and Regulate Ferroptosis in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-173980/v1↗
  10. Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells. Last author DOI 10.2147/ott.s223242↗
  11. B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.20421↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingming Kong · 3 shared papers, 2024–2026 · strength 0.91
  2. Zhenyan Pan · 2 shared papers, 2024–2026 · strength 0.55
  3. Wei‐Ming Wang · 2 shared papers, 2021–2024 · strength 0.40
  4. Xiang Zhou · 1 shared paper, 2026 · strength 0.36
  5. Bingren Hu · 2 shared papers, 2019–2023 · strength 0.32
  6. Jiuyi Zheng · 2 shared papers, 2021–2024 · strength 0.32
  7. Xiang Zhou · 1 shared paper, 2024 · strength 0.28
  8. Qiandong Zhu · 1 shared paper, 2026 · strength 0.27
  9. Xinwei Chen · 1 shared paper, 2023 · strength 0.20
  10. Siming Chen · 1 shared paper, 2025 · strength 0.20
  11. Yanxia Ru · 1 shared paper, 2025 · strength 0.20
  12. Zhipeng Li · 1 shared paper, 2022 · strength 0.17
  13. Bo Peng · 1 shared paper, 2022 · strength 0.17
  14. Bo Chen · 1 shared paper, 2021 · strength 0.13
  15. Yi Wang · 1 shared paper, 2021 · strength 0.12
  16. Xiang Zhou · 1 shared paper, 2021 · strength 0.12
  17. Yunfeng Shan · 1 shared paper, 2021 · strength 0.12
  18. Xin Zhao · 1 shared paper, 2017 · strength 0.06
  19. Dongming Zhu · 1 shared paper, 2017 · strength 0.06
  20. Dongbao Li · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.